Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant ?-interferon for chronic non-A, non-B hepatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant ?-interferon for chronic non-A, non-B hepatitis

Published:1991-09 Issue:9 Volume:36 Page:1217-1222
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Digest Dis Sci

Author:

Omata Masao,Ito Yoshimi,Yokosuka Osamu,Imazeki Fumio,Tagawa Masami,Takano Susumu,Hosoda Kazuhiko,Tada Minoru,Ohto Masao,Ito Kazuto,Okuda Kunio

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/BF01307512.pdf

Reference11 articles.

1. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Bisceglie AD, Peters M, Waggoner JG, Park Y, Jones EA: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 315:1575?1578, 1986

2. Omata M, Ito Y, Yokosuka O, Imazeki F, Uchiumi K, Takano S, Hosoda K, Ohto M: Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B. Dig Dis Sci 34:330?337, 1989

3. Baglioni C: Interferon induced enzymatic activities and their role in the antiviral state. Cell 17:255?264, 1979

4. Sawai H, Ishibashi K, Itoh M, et al: Sensitive radioimmunoassay for 2?,5?-oligoadenylates using a novel125I-labeled derivatives of 2?-5?-triadenylate 5?-triphosphate. J Biochem 98:999?1005, 1985

5. Omata M, Imazeki F, Yokosuka O, Ito Y, Uchiumi K, Mori J, Okuda K: Recombinant leukocyte A interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects. Gastroenterology 88:870?880, 1985

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin;Hepatology International;2015-08-12

2. A decade of trials of interferon-alpha for chronic hepatitis C. A meta-regression analysis;Contemporary Clinical Trials;2005-04

3. The Impact of Antiviral Treatments on the Course of Chronic Hepatitis C: An Evidence-Based Approach;Current Pharmaceutical Design;2004-07-01

4. IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C;Clinical and Experimental Immunology;2001-10

5. Interferon Therapy in Liver Cirrhosis Type C;Journal of Pharmacy Technology;2000-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3